The move — along with the CDC’s explanation — is a sign that the nation’s top public health agency may be falling in line ...

Over a month into Robert F. Kennedy Jr.’s tenure as HHS Secretary, leaders in pharma, medical marketing and media circles are ...

The bill, which sailed through the Montana House 98-1 in early March and is now before the state Senate, would set a price floor that PBMs must pay pharmacies for each prescription.

Five chief creative officers from leading medical marketing agencies weigh in on how the job has changed and where it’s going.

Legal challenges to mifepristone raise questions for medical marketers about what implications this holds for the future of advertising drugs and products connected to women’s reproductive health.

CDC deputy director of public affairs Nina Witkofsky is serving as acting director of communications following Griffis’ exit.

One pharma company is taking an unconventional approach to heart disease awareness: launching a drone show to educate people ...

From muddying the waters on vaccine policy to espousing MAHA, Kennedy’s first month in office offers a glimpse into the next ...

Proprietary listener insights that demonstrate why streaming audio should be an integral part of a pharma marketer’s media ...

Merck signed a licensing agreement for a heart disease drug with Jiangsu Hengrui Pharmaceuticals worth up to $2 billion.

Eli Lilly is expanding care offerings on its direct-to-consumer (DTC) platform LillyDirect, now offering connections to ...

Griffis wrote in a Washington Post op-ed that he believes public health policy must always ‘be guided by facts and not ...